Quamed News

Medical Product Alert N° 11/2019

31 July 2020

Quamed News

Medical Product Alert N° 11/2019

31 July 2020

Falsified Amoxicillin + Clavulanic Acid products circulating in Haiti

This Medical Product Alert relates to two confirmed falsified versions of amoxicillin + clavulanic acid products circulating in Haiti, presented under the names “Augmentin and Amoxicillin Clavulanate Potassium” and “Bactoclav”.

Genuine amoxicillin + clavulanic acid is used to treat a range of bacterial infections and is referenced on the WHO Essential Medicines List as an access group antibiotic.

WHO was informed by the Haiti Ministère de la Santé Publique et de la Population (MSPP) and Caribbean Public Health Agency’s (CARPHA) VigiCarib network (which is a regional reporting system for pharmacovigilance and post market surveillance), that falsified “Augmentin and Amoxicillin Clavulanate Potassium” and “Bactoclav” were found in a pharmacy in Haiti. At this stage, laboratory testing of these products is being facilitated. Product details are listed in the tables below.

1. Augmentin and Amoxicillin Clavulanate Potassium

Table 1: Details of the falsified product Augmentin and Amoxicillin Clavulanate Potassium, subject of WHO medical product alert N°11/2019

Download

ALSO READ

En poursuivant votre visite sur ce site, vous acceptez l'utilisation de cookies En savoir plus

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close